Alpha 2.0
Login Register
» Authors » J Anthony G Scott

J Anthony G Scott

Explore the profile of J Anthony G Scott including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 205
Citations 7533
Followers 0
Related Specialties
Infectious Diseases
General Medicine
Public Health
Top 10 Co-Authors
Laura L Hammitt
Karen L Kotloff
Shabir A Madhi
Katherine L OBrien
Orin S Levine
Daniel R Feikin
David R Murdoch
Thomas N Williams
W Abdullah Brooks
Susan C Morpeth
Published In
Clin Infect Dis
Lancet Glob Health
PLoS One
Lancet
Vaccine
Affiliations
Soon will be listed here.
Recent Articles
1.
Investigating the role of cytomegalovirus as a cause of stillbirths and child deaths in low and middle-income countries through postmortem minimally invasive tissue sampling
Velaphi S, Madewell Z, Tippett-Barr B, Blau D, Lala S, Mahtab S, et al.
Clin Infect Dis . 2025 Mar; PMID: 40059623
Background: There is paucity of information on the role of cytomegalovirus (CMV) infection as a cause of stillbirths or childhood deaths in low-and middle-income countries (LMICs). We investigated attribution of...
2.
Effect of mass campaigns with full and fractional doses of pneumococcal conjugate vaccine (Pneumosil) on the reduction of nasopharyngeal pneumococcal carriage in Niger: a three-arm, open-label, cluster-randomised trial
Coldiron M, Soumana I, Baudin E, Langendorf C, Mamiafo Tchoula C, Brah S, et al.
Lancet Infect Dis . 2025 Jan; PMID: 39798587
Background: In settings with low pneumococcal conjugate vaccine (PCV) coverage, multi-age cohort mass campaigns could increase population immunity, and fractional dosing could increase affordability. We aimed to evaluate the effect...
3.
Evaluation of population immunity against SARS-CoV-2 variants, EG.5.1, FY.4, BA.2.86, JN.1, JN.1.4, and KP.3.1.1 using samples from two health demographic surveillance systems in Kenya
Lugano D, Kutima B, Kimani M, Sigilai A, Gitonga J, Karani A, et al.
BMC Infect Dis . 2024 Dec; 24(1):1474. PMID: 39732637
Increased immune evasion by emerging and highly mutated SARS-CoV-2 variants is a key challenge to the control of COVID-19. The majority of these mutations mainly target the spike protein, allowing...
4.
Contribution of malnutrition to infant and child deaths in Sub-Saharan Africa and South Asia
Madewell Z, Keita A, Das P, Mehta A, Akelo V, Oluoch O, et al.
BMJ Glob Health . 2024 Dec; 9(12). PMID: 39638608
Introduction: Malnutrition contributes to 45% of all childhood deaths globally, but these modelled estimates lack direct measurements in countries with high malnutrition and under-5 mortality rates. We investigated malnutrition's role...
5.
Etiologies and comorbidities of meningitis deaths in children under 5 years in high-mortality settings: Insights from the CHAMPS Network in the post-pneumococcal vaccine era
Mahtab S, Madewell Z, Baillie V, Dangor Z, Lala S, Assefa N, et al.
J Infect . 2024 Nov; 89(6):106341. PMID: 39521254
Background: The role of meningitis in causing deaths and in children under 5 is unclear, especially since widespread use of vaccines to prevent common causes of meningitis. Child Health and...
6.
Epidemiology of human metapneumovirus among children with severe or very severe pneumonia in high pneumonia burden settings: the Pneumonia Etiology Research for Child Health (PERCH) study experience
Miyakawa R, Zhang H, Brooks W, Prosperi C, Baggett H, Feikin D, et al.
Clin Microbiol Infect . 2024 Nov; 31(3):441-450. PMID: 39489292
Objectives: After respiratory syncytial virus (RSV), human metapneumovirus (hMPV) was the second-ranked pathogen attributed to severe pneumonia in the PERCH study. We sought to characterize hMPV-positive cases in high-burden settings,...
7.
Fractional Doses of Pneumococcal Conjugate Vaccine - A Noninferiority Trial
Gallagher K, Lucinde R, Bottomley C, Kaniu M, Suaad B, Mutahi M, et al.
N Engl J Med . 2024 Sep; 391(21):2003-2013. PMID: 39330966
Background: Pneumococcal conjugate vaccines are an expensive component of the routine immunization schedule. Fractional-dose regimens may be one option to increase the sustainability of the vaccine program. Methods: We assessed...
8.
Re-evaluating the impact and cost-effectiveness of pneumococcal conjugate vaccine introduction in 112 low-income and middle-income countries in children younger than 5 years: a modelling study
Chen C, Ang G, Akksilp K, Koh J, Scott J, Clark A, et al.
Lancet Glob Health . 2024 Aug; 12(9):e1485-e1497. PMID: 39151983
Background: Streptococcus pneumoniae has been estimated to cause 9·18 million cases of pneumococcal pneumonia, meningitis, and invasive non-pneumonia non-meningitis disease and 318 000 deaths among children younger than 5 years...
9.
Circumstances for treatment and control of invasive Enterobacterales infections in eight hospitals across sub-Saharan Africa: a cross-sectional study
Aiken A, Nyamwaya B, Madrid L, Edessa D, Labi A, Obeng-Nkrumah N, et al.
Gates Open Res . 2024 Mar; 7:21. PMID: 38532981
Bloodstream infections caused by Enterobacterales show high frequency of antimicrobial resistance (AMR) in many Low- and Middle-Income Countries. We aimed to describe the variation in circumstances for management of such...
10.
Factors predicting mortality in hospitalised HIV-negative children with lower-chest-wall indrawing pneumonia and implications for management
Gallagher K, Awori J, Knoll M, Rhodes J, Higdon M, Hammitt L, et al.
PLoS One . 2024 Mar; 19(3):e0297159. PMID: 38466696
Introduction: In 2012, the World Health Organization revised treatment guidelines for childhood pneumonia with lower chest wall indrawing (LCWI) but no 'danger signs', to recommend home-based treatment. We analysed data...